TLR4 基因变异与儿童 ITP 患者激素无反应相关
研究对儿童免疫性血小板减少症(ITP)患者进行全外显子测序,发现 TLR4 两个错义单核苷酸变异(D299G 和 T399I)在激素无反应者中频率更高,并在独立队列中验证了该趋势。
要点
- TLR4 D299G 和 T399I 在激素无反应儿童 ITP 中频率显著高于有反应者。
- 该发现可能为 ITP 激素反应预测提供遗传标志物。
- 结果需前瞻性验证以指导个体化治疗。
核心结论
- TLR4 两个错义变异与儿童 ITP 患者激素无反应相关,可能具有预后意义。
研究设计与样本
- 对儿童 ITP 队列进行全外显子测序,并在独立儿童 ITP 队列中对两个 SNV 直接基因分型验证。
主要发现
- 在激素无反应的白种人儿童 ITP 患者中,TLR4 D299G(rs4986790)和 T399I(rs4986791)的次要等位基因频率均为 20.7%。
- 在激素有反应者中,D299G 和 T399I 的等位基因频率分别为 2.3% 和 3.4%(P < .001)。
- 独立队列中观察到与上述结果一致的趋势。
临床怎么用
- TLR4 基因分型可能有助于预测儿童 ITP 患者对一线激素治疗的反应。
局限性
- 研究为回顾性设计,样本量未报告,需前瞻性研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Although the most common front-line therapies for immune thrombocytopenia (ITP) have been in use for decades, it is still not possible to predict an individual patient's clinical course and response to therapy. Patients are managed with a trial-and-error approach and often suffer side effects of therapies which could have been avoided if response prediction were possible. Corticosteroids are the most frequently used upfront therapy for adults and children with ITP. Our group performed whole exome sequencing on a cohort of pediatric ITP patients, and identified two missense single nucleotide variants (SNV) in Toll-like receptor 4 (TLR4). These coding variants in TLR4 had an increased frequency in Caucasian patients with poor response to upfront steroid therapy. Both TLR4 (D299G; rs4986790) and TLR4 (T399I; rs4986791) had a minor allele frequency (MAF) of 20.7% in those patients unresponsive to steroids, but were present at lower allele frequencies of 2.3% and 3.4% in responders respectively (P < .001). These findings were consistent with the trend identified in an independent cohort of pediatric ITP patients treated with corticosteroids who underwent direct genotyping for both SNVs. This study identified two candidate genetic variants in two unique cohorts of ITP patients which may contribute to steroid response and have prognostic implications for treatment response in ITP.
引用
- Kim TO, Flanagan JM, Habibi A, et al. Genetic variants in toll-like receptor 4 are associated with lack of steroid-responsiveness in pediatric ITP patients. Am J Hematol. 2020. PMID: 31903617. doi:10.1002/ajh.25716
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。